Identification of surface-associated antigens for tumor diagnosis and therapy

Details for Australian Patent Application No. 2005244425 (hide)

Owner Ganymed Pharmaceuticals AG

Inventors Schluter, Volker; Thiel, Philippe; Usener, Dirk; Tureci, Ozlem; Sahin, Ugur; Helftenbein, Gerd; Schneider, Sandra; Koslowski, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005244425

PCT Pub. Number WO2005/110338

Priority 10 2004 023 187.7 11.05.04 DE

Filing date 11 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 13 October 2011

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/110338 Priority application(s): WO2005/110338

8 April 2010 Amendment Made

  The nature of the amendment is: Add co-inventor Koslowski, Michael 2006

13 October 2011 Application Accepted

  Published as AU-B-2005244425

9 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244429-Personal liquid cleanser composition stabilized with a starch structuring system

2005244424-Inhalation powder formulations containing enantiomerically pure beta-agonists